Jaiswal A K, Nebert D W, Eisen H W
Biochem Pharmacol. 1985 Aug 1;34(15):2721-31. doi: 10.1016/0006-2952(85)90573-8.
The human MCF-7 and the mouse Hepa-1 cell culture lines were compared for aryl hydrocarbon hydroxylase and acetanilide 4-hydroxylase inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and benzo[a]anthracene (BA) and TCDD- and BA-specific binding in the cytosol and nucleus. The effective concentration of BA in the growth medium required to induce either enzyme to 50% of its maximally inducible activity (EC50) was the same (5-11 microM) in both MCF-7 and Hepa-1 cells. On the other hand, the EC50 for TCDD in MCF-7 cells (5-25 nM) was more than 40-fold greater than that in Hepa-1 cells (0.4 to 0.6 nM). P1-450- and P3-450-specific mouse cDNA probes were used to quantitate mRNA induction in the Hepa-1 cell line. P1-450 mRNA was induced markedly by TCDD and benzo[a] anthracene, whereas P3-450 mRNA was induced negligibly. A P1-450-specific human cDNA probe was used to quantitate P1-450 mRNA induction in the MCF-7 cell line. Aryl hydrocarbon hydroxylase inducibility by TCDD or BA always paralleled P1-450 mRNA inducibility in either the mouse or human line. Although the cytosolic Ah receptor in Hepa-1 cells was easily detected by sucrose density gradient centrifugation, gel permeation chromatography, and anion-exchange high-performance liquid chromatography, the cytosolic receptor cannot be detected in MCF-7 cells. Following in vivo exposure of cultures to radiolabeled TCDD, the intranuclear concentration of inducer-receptor complex was at least fifty times greater in Hepa-1 than MCF-7 cultures. The complete lack of measurable cytosolic receptor and almost totally absent inducer-receptor complex in the nucleus of MCF-7 cells was, therefore, out of proportion to its capacity for aryl hydrocarbon hydroxylase and acetanilide 4-hydroxylase inducibility. This MCF-7 line should provide an interesting model for a better understanding of the mechanisms of drug-metabolizing enzyme induction by polycyclic aromatic compounds, including the Ah receptor-mediated mechanism.
比较了人MCF - 7和小鼠Hepa - 1细胞系对2,3,7,8 - 四氯二苯并 - p - 二恶英(TCDD)和苯并[a]蒽(BA)诱导芳烃羟化酶和对乙酰氨基酚4 - 羟化酶的能力,以及TCDD和BA在胞质溶胶和细胞核中的特异性结合。在MCF - 7和Hepa - 1细胞中,将两种酶诱导至其最大诱导活性的50%(EC50)所需的生长培养基中BA的有效浓度相同(5 - 11 microM)。另一方面,MCF - 7细胞中TCDD的EC50(5 - 25 nM)比Hepa - 1细胞中的EC50(0.4至0.6 nM)大40多倍。使用P1 - 450和P3 - 450特异性小鼠cDNA探针来定量Hepa - 1细胞系中的mRNA诱导情况。P1 - 450 mRNA被TCDD和苯并[a]蒽显著诱导,而P3 - 450 mRNA的诱导可忽略不计。使用P1 - 450特异性人cDNA探针来定量MCF - 7细胞系中P1 - 450 mRNA的诱导情况。TCDD或BA诱导的芳烃羟化酶能力总是与小鼠或人细胞系中P1 - 450 mRNA的诱导情况平行。尽管通过蔗糖密度梯度离心、凝胶渗透色谱和阴离子交换高效液相色谱很容易检测到Hepa - 1细胞中的胞质Ah受体,但在MCF - 7细胞中无法检测到胞质受体。在将培养物体内暴露于放射性标记的TCDD后,Hepa - 1细胞中核内诱导剂 - 受体复合物的浓度至少比MCF - 7细胞培养物高50倍。因此,MCF - 7细胞完全缺乏可测量的胞质受体且细胞核中几乎完全没有诱导剂 - 受体复合物,这与其芳烃羟化酶和对乙酰氨基酚4 - 羟化酶的诱导能力不相称。MCF - 7细胞系应该为更好地理解包括Ah受体介导机制在内的多环芳烃化合物诱导药物代谢酶的机制提供一个有趣的模型。